Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Syngenta bids for Devgen takeover

Syngenta is to bid €16 ($21) a share to acquire Belgian biotechnology company, Devgen (Ghent). The bid is supported by “a number of major shareholders holding approximately 48%” of shares, Syngenta says. That values the company at some €403 million ($529 million), Syngenta says. The offer requires the acceptance of 80% of value shareholders, and the condition that Devgen “does not suffer a material adverse change before the results of the offer are published”. Full details will be released in the offer prospectus following the Devgen reply and approval by the Belgian regulator, the FSMA. The companies have recently agreed a six-year deal for Syngenta’s use of Devgen’s RNA interference technology platform in its crop protection pipeline ( Agrow No 640, p 4).


What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts